Pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 pharmaceutical companies ranked by one-year price change, at +403%, ahead of Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%). Figures as of 18 Nov 2026, 19:01 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+403%
- Median
- +26.9%
- Combined market value
- SAR 19.06T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +403% | SAR 17.6B | SAR 50.23 | 3.60% down | 403% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +286% | SAR 34.5B | SAR 363.02 | 3.17% up | 286% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +241% | SAR 24.4B | SAR 360.10 | 0.33% down | 241% up | ||
| 4 | VeradermicsMANE · Health Care | +233% | SAR 19.7B | SAR 467.86 | 0.72% down | 233% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +169% | SAR 14.8B | SAR 107.95 | 2.04% down | 169% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | SAR 28B | SAR 356.91 | 0.04% up | 126% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +113% | SAR 18.4B | SAR 326.58 | 0.10% up | 113% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | +107% | SAR 37.5B | SAR 247.94 | 5.41% up | 107% up | ||
| 9 | ViatrisVTRS · Health Care | +95.5% | SAR 89.1B | SAR 77.72 | 1.32% up | 96% up | ||
| 10 | Roivant SciencesROIV · Health Care | +90.3% | SAR 104.8B | SAR 144.57 | 0.43% down | 90% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | SAR 17.1B | SAR 156.27 | 0.90% down | 88% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | SAR 28.8B | SAR 82.67 | 4.36% up | 83% up | ||
| 13 | Royalty PharmaRPRX · Health Care | +77.7% | SAR 149.7B | SAR 260.36 | 1.06% up | 78% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | SAR 184.2B | SAR 157.88 | 1.24% down | 74% up | ||
| 15 | GenmabGMAB · Health Care | +70.0% | SAR 119.1B | SAR 193.10 | 0.92% down | 70% up | ||
| 16 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | SAR 32.3B | SAR 1,155.31 | 0.96% up | 61% up | ||
| 17 | AlkermesALKS · Health Care | +58.4% | SAR 29.6B | SAR 175.87 | 3.16% up | 58% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +53.6% | SAR 256B | SAR 80.12 | 1.29% down | 54% up | ||
| 19 | Merck & CoMRK · Health Care | +50.8% | SAR 1.28T | SAR 518.10 | 3.66% down | 51% up | ||
| 20 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | SAR 30.8B | SAR 472.21 | 0.98% up | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | +44.2% | SAR 18.4B | SAR 191.64 | 0.02% down | 44% up | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | SAR 22.7B | SAR 1,132.45 | 2.76% up | 43% up | ||
| 23 | Johnson & JohnsonJNJ · Health Care | +37.6% | SAR 2.48T | SAR 1,030.47 | 1.43% down | 38% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | SAR 59.5B | SAR 926.22 | 2.58% up | 37% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | SAR 367.7B | SAR 3,554.52 | 1.06% down | 36% up | ||
| 26 | Eli LillyLLY · Health Care | +34.9% | SAR 4.65T | SAR 5,218.43 | 1.72% down | 35% up | ||
| 27 | Bristol-Myers SquibbBMY · Health Care | +34.0% | SAR 460.3B | SAR 225.19 | 2.14% down | 34% up | ||
| 28 | Belite BioBLTE · Health Care | +31.0% | SAR 24B | SAR 591.53 | 0.01% down | 31% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | SAR 22.6B | SAR 345.65 | 0.22% up | 31% up | ||
| 30 | Ascendis PharmaASND · Health Care | +27.8% | SAR 66.6B | SAR 1,015.96 | 0.13% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | SAR 512.4B | SAR 2,021.15 | 0.87% up | 27% up | ||
| 32 | AbbVieABBV · Health Care | +25.7% | SAR 1.9T | SAR 1,076.44 | 2.00% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +25.0% | SAR 1.1T | SAR 584.39 | 2.10% down | 25% up | ||
| 34 | United TherapeuticsUTHR · Health Care | +22.6% | SAR 93B | SAR 2,182.63 | 0.38% down | 23% up | ||
| 35 | Elanco Animal HealthELAN · Health Care | +20.5% | SAR 50.4B | SAR 100.83 | 3.98% up | 20% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +17.2% | SAR 57.1B | SAR 292.88 | 1.67% up | 17% up | ||
| 37 | BeOne MedicinesONC · Health Care | +16.8% | SAR 173.5B | SAR 1,518.63 | 2.03% down | 17% up | ||
| 38 | PfizerPFE · Health Care | +14.4% | SAR 601.5B | SAR 105.53 | 1.18% down | 14% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | SAR 31.4B | SAR 453.23 | 3.62% up | 13% up | ||
| 40 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | SAR 44.1B | SAR 227.65 | 3.73% up | 11% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | SAR 23B | SAR 162.70 | 0.90% up | 10% up | ||
| 42 | GSKGSK · Health Care | +6.26% | SAR 366.4B | SAR 182.80 | 1.03% down | 6% up | ||
| 43 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | SAR 47B | SAR 56.36 | 1.59% up | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +2.41% | SAR 1.04T | SAR 672.74 | 1.60% down | 2% up | ||
| 45 | GrifolsGRFS · Health Care | +1.41% | SAR 21.6B | SAR 31.70 | 2.09% down | 1% up | ||
| 46 | SanofiSNY · Health Care | -4.08% | SAR 425.7B | SAR 177.27 | 0.57% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -7.37% | SAR 26.6B | SAR 505.00 | 0.97% down | 7% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -7.92% | SAR 27.9B | SAR 254.67 | 3.10% down | 8% down | ||
| 49 | Novo NordiskNVO · Health Care | -16.9% | SAR 653B | SAR 148.16 | 2.95% down | 17% down | ||
| 50 | Abbott LaboratoriesABT · Health Care | -17.0% | SAR 678.9B | SAR 391.98 | 0.20% down | 17% down | ||
| 51 | PTC TherapeuticsPTCT · Health Care | -20.2% | SAR 18.9B | SAR 226.19 | 0.10% down | 20% down | ||
| 52 | CytokineticsCYTK · Health Care | -20.3% | SAR 26.9B | SAR 192.86 | 0.45% down | 20% down | ||
| 53 | Cogent BiosciencesCOGT · Health Care | -20.3% | SAR 18.2B | SAR 104.88 | 0.39% up | 20% down | ||
| 54 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | SAR 35.4B | SAR 1,522.04 | 3.84% down | 24% down | ||
| 55 | ABIVAXABVX · Health Care | -27.3% | SAR 27.5B | SAR 314.50 | 2.13% up | 27% down | ||
| 56 | ZoetisZTS · Health Care | -28.7% | SAR 129.9B | SAR 319.70 | 2.10% up | 29% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -35.6% | SAR 31.6B | SAR 39.52 | 1.27% down | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.1% | SAR 99.1B | SAR 451.83 | 1.15% down | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -42.5% | SAR 11.8B | SAR 60.84 | 0.68% up | 42% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | SAR 17.5B | SAR 104.88 | 3.71% up | 64% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | SAR 75.6B | SAR 564.28 | 3.88% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which pharmaceutical companies rank first by one-year price change?
Erasca (+403%), Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%) are the top three of the 61 pharmaceutical companies ranked by one-year price change as of 18 Nov 2026, 19:01 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by one-year price change have a combined market value of SAR 19.06T as of 18 Nov 2026, 19:01 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.